
Triwin Pharmaceuticals Limited
This company trades and manufactures pharmaceutical products, including drugs, chemicals, and body care products.
This company trades and manufactures pharmaceutical products, including drugs, chemicals, and body care products.
Triwin Pharmaceuticals Limited (TPL) is a Public Limited Indian Non-Government Company incorporated in India on 11 August 1995 and has a history of 29 years and six months. Its registered office is in Tirupati., Andhra Pradesh.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹3.10 M. The company has closed loans amounting to ₹3.34 Cr, as per Ministry of Corporate Affairs (MCA) records.
Harish Gontumukkala, Gontumukkala Harini, Hrithika Gontumukkala, and One other member serve as directors at the Company.
+91-XXXXXXXXXX
-
U24230AP1995PLC021384
021384
Public Limited Indian Non-Government Company
11 Aug 1995
30 Sep 2024
31 Mar 2024
Unlisted
Roc Vijayawada
Name | Designation | Appointment Date | Status |
---|---|---|---|
Harish Gontumukkala ![]() | Managing Director | 26-May-2011 | Current |
Name | Designation | Appointment Date | Status |
---|---|---|---|
Gontumukkala Harini ![]() | Director | 26-May-2011 | Current |
Hrithika Gontumukkala ![]() | Director | 15-Jun-2024 | Current |
Bhagya Wootla ![]() | Director | 23-Dec-2011 | Current |
Triwin Pharmaceuticals Limited, for the financial year ended 2017, experienced Minor drop in revenue, with a 1.46% decrease. The company also saw a substantial fall in profitability, with a 60.43% decrease in profit. The company's net worth Soared by an impressive increase of 177.38%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2017, Triwin Pharmaceuticals had a promoter holding of 99.92% and a public holding of 0.08%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Gontumukkala Harini and Hrithika Gontumukkala are mutual person
₹3.10 M
₹33.40 M
Date | Lender | Amount | Status |
---|---|---|---|
09 Sep 1995 | Andhra Pradesh State Financial Corporation | ₹3.10 M | Open |
19 Feb 2013 | State Bank Of India | ₹2.00 Cr | Satisfied |
03 Sep 1998 | Bank Of India | ₹3.00 M | Satisfied |
17 Aug 1998 | Bank Of India | ₹2.40 M | Satisfied |
19 Jul 1996 | Bank Of India | ₹8.00 M | Satisfied |
Unlock and access historical data on people associated with Triwin Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Triwin Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Triwin Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Triwin Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Hrithika Gontumukkala was appointed as a Director was appointed as a Director on 15 Jun 2024 & has been associated with this company since 8 months 18 days .
Triwin Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Vijayawada.
A charge registered on 19 Feb 2013 via Charge ID 10419225 with State Bank Of India was fully satisfied on 16 Dec 2017.
A charge with State Bank Of India amounted to Rs. 20.00 M with Charge ID 10419225 was registered on 19 Feb 2013.
Bhagya Lakshmi Wootla was appointed as a Director was appointed as a Director on 23 Dec 2011 & has been associated with this company since 13 years 2 months .
Triwin Pharmaceuticals Limited was incorporated on 11 Aug 1995.
The authorized share capital of Triwin Pharmaceuticals Limited is ₹ 1.00 M and paid-up capital is ₹ 0.50 M.
Currently 4 directors are associated with Triwin Pharmaceuticals Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Triwin Pharmaceuticals Limited is 23 24 Settipalli Industrial Estate, India, Tirupati., Andhra Pradesh.
The corporate identification number (CIN) of Triwin Pharmaceuticals Limited is U24230AP1995PLC021384 and the company number is 021384 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2017, the revenue trend for Triwin Pharmaceuticals Limited has fallen by -1.46%.
The financial reports for the fiscal year 2017 indicates that The net worth of Triwin Pharmaceuticals Limited has experienced an upsurge of 177.38%.
As per the financial statements for fiscal Year 2017, The total open charges for Triwin Pharmaceuticals Limited amount to ₹ 3.10 M.
The most recent Balance Sheet for Triwin Pharmaceuticals Limited was filed with the ROC on 31 Mar 2024.
PC
KP
CK
GR
JM
MG
GM